Table 3 Findings of two-sample MR investigating effects of genetically predicted GrimAA on cognitive function based on primary method and pleiotropy-robust methods
Outcome | Exposure genetic instruments | Primary analysis | Sensitivity analysis | |||||
|---|---|---|---|---|---|---|---|---|
Egger intercept P | Method | Effecta (95% CI) | Pb | Method | Effecta (95% CI) | P | ||
Trail making tests | GrimAA 4 SNPs | 0.34 | IVW | 0.024 (0 to 0.049) | 0.05 | Weighted median | 0.015 (−0.015 to 0.045) | 0.32 |
Parts A (N = 99,479) | Weighted mode | 0.014 (−0.031 to 0.059) | 0.59 | |||||
Trail making tests | GrimAA 4 SNPs | 0.54 | IVW | 0.022 (−0.015 to 0.059) | 0.25 | Weighted median | 0.011 (−0.021 to 0.043) | 0.49 |
Parts B (N = 99,477) | Weighted mode | 0.007 (−0.043 to 0.058) | 0.79 | |||||
Numeric memory (N = 106,162) | GrimAA 4 SNPs | 0.55 | IVW | 0.97 (0.94 to 1.01) | 0.14 | Weighted median | 0.98 (0.94 to 1.02) | 0.31 |
Weighted mode | 0.98 (0.93 to 1.04) | 0.61 | ||||||